Safety and feasibility of using serial infusions of nesiritide for heart failure in an outpatient setting (from the FUSION I trial)
Clyde W. Yancy(Northwestern Memorial Hospital), Marc A. Silver(Banner - University Medical Center Phoenix), Barry Bertolet, Mitchell Saltzberg(Heart Foundation), Krishnaswami Vijayaraghavan(Arizona Heart Institute), Kirk Walker(Cascade (United States)), Darlene P. Horton(Scion), Ron M. Oren(University of Iowa Hospitals and Clinics), Kenneth Burnham, Robert Berkowitz(Hackensack University Medical Center)
Cited by 103
Related Papers
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
|Circulation|2014|7.1k
Defining and Setting National Goals for Cardiovascular Health Promotion and Disease Reduction
|Circulation|2010|4.8k
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
|Circulation|2011|2.1k
Characteristics and outcomes of patients hospitalized for heart failure in the United States: Rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE)
|American Heart Journal|2005|2.1k
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
|Journal of the American College of Cardiology|2011|1.3k